CAS: 351-35-9; 3-(Trifluoromethyl)Phenylacetic Acid

上下游产品

CAS号2338-76-3 间三氟甲基苯乙腈 | CAS号201230-82-2 carbon monoxide | CAS号705-29-3 3-三氟甲基氯苄 | CAS号110-91-8 吗啉 | CAS号124-38-9 二氧化碳 | CAS号349-75-7 3-(三氟甲基)苄醇 | CAS号2003-14-7 3-(三氟甲基)苯基乙酰氯 | CAS号402-26-6 间(三氟甲基)苯基溴化镁 | CAS号402-23-3 3-(三氟甲基)苯甲酰溴 | CAS号454-92-2 3-三氟甲基苯甲酸 | CAS号455-01-6 3-(三氟甲基)苯乙醇 | CAS号331-33-9 2-(3-(三氟甲基)苯基)乙酸乙酯 | CAS号2003-14-7 3-(三氟甲基)苯基乙酰氯 | CAS号21172-31-6 2-(3-(三氟甲基)苯基)乙醛 | CAS号1997-80-4 1-(2-溴乙基)-3-(三氟甲基)苯 | CAS号62451-84-7 3-三氟甲基苯乙酸甲酯 | CAS号346672-98-8 N-METHOXY-N-MET... | CAS号29270-33-5 α-溴-4-氟苯乙酸 | CAS号133464-31-0 2-bromo-2-[m-(t... | CAS号894802-88-1 3-oxo-4-(3-trif...

3-三氟甲基苯甲醇置于氯化亚砜体系中,化学反应生成间三氟甲基苯乙酸
参考文献:光化学反应.第63篇[1].α-芳基醛的光脱羰
标题:光化学反应.第63篇[1].α-芳基醛的光脱羰
摘要:醛的紫外线照射6-11在排他地在脱羰基的主要产品脱气的解决方案的结果34,35和37-40,以及少量的2,3-二苯基2,3二甲基丁烷36从苯基醛6和7.在三-的存在ñ-Butylstannane,锡烷氢竞速赛的掺入,对具体底物的限制,并在分子内氘转移7 35和11 40.对于苯醛6和苯甲醛,脱羰基的量子产率为φ〜0.4-1.0.9,和0.02 8.哈米特φ与共振常数(相关性[r )为6(x = H,P-Ch 3,och 3)和(cf 3)中,用ω米+为值元取代的异构体是与拟议的将α-裂解为仅具有中等自由基特征的相关自由基对作为主要的光化学步骤相一致.
Doi:10.1002/hlca.19710540312

专利信息

专利号:US-9181292-B2
优先权日:2011-01-05
标题 :Methods for preparation of glycosphingolipids and uses thereof
发明人：LIANG PI-HUI
权利人:LIANG PI-HUI
摘要:Methods for synthesis and preparation of alpha-glycosphingolipids are provided. Methods for synthesis of α-galactosyl ceramide, and pharmaceutically active analogs and variants thereof are provided. Novel alpha-glycosphingolipids are provided, wherein the compounds are immunogenic compounds which serve as ligands for NKT (natural killer T) cells.

专利号:US-6664282-B2
优先权日:1999-09-17
标 题:Synthesis of [3,5,7]-1H-imidazo [1,5-a]imidazol-2 (3H)- one compounds
发明人：ELABDELLAOUI HASSAN M; OSTRESH JOHN M; HOUGHTEN RICHARD A
权利人:TORREY PINES INST
摘要:Individual substituted [3,5,7]-1H-imidazo[1,5-a]imidazol-2(3H)-one compounds and their pharmaceutically-acceptable salts are disclosed, as are libraries of such compounds. Methods of preparing and using the libraries of compounds as well as individual compounds of the libraries are also disclosed.

专利号:US-4426536-A
优先权日:1982-06-14
标 题:Synthesis of phenylacetic acid esters
发明人：ROBEY ROGER L
权利人:LILLY CO ELI
摘要:Esters of phenylacetic acids are prepared in a single step by hydrolysis of 2,2,2-trichloro-1-phenylethanes in inorganic basic media.

专利号:EP-0946499-B1
优先权日:1996-11-22
标 题 :N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
发明人：WU JING; TUNG JAY S; NISSEN JEFFREY S; MABRY THOMAS E; LATIMER LEE H; EID CLARK NORMAN; AUDIA JAMES E
权利人:ELAN PHARM INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions. Said compounds are represented by formula (I), wherein R<1> is selected from the group consisting of: a) alkyl, alkenyl, alkaryl, alkcycloalkyl, aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocyclic; b) a substituted phenyl group of formula (II), wherein R is alkylene of from 1 to 8 carbon atoms, m is an integer equal to 0 or 1, and c) 1- or 2-naphthyl substituted at the 5, 6, 7 and/or 8 positions, R<2> is selected from the group consisting of hydrogen, alkyl of from 1 to 4 carbon atoms, alkylalkoxy of from 1 to 4 carbon atoms, alkylthioalkoxy of from 1 to 4 carbon atoms; and R<3> and R<3'> are independently selected from the group consisting of: (a) hydrogen, (b) alkyl, (c) -(R<7>)n(W)p, wherein R<7> is an alkylene group, W is selected from the group consisting of (i) formula (A); (ii) heteroaryl; and (iii) N-heterocyclic, and n is an integer equal to 0 or 1, and p is an integer equal to 1 to 3; (d) -CH( phi )CH2C(O)O-Q where Q is selected from the group consisting of alkyl, aryl, heteroaryl and heterocyclic; X' is hydrogen, hydroxy or fluoro; X'' is hydrogen, hydroxy or fluoro, or X' and X'' together form an oxo group, Z is selected from the group consisting of a bond covalently linking R<1> to -CX'X''-, oxygen and sulfur.

专利号:US-6849650-B2
优先权日:1998-02-27
标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人：THORSETT EUGENE D; PORTER WARREN J; NISSEN JEFFREY S; LATIMER LEE H; AUDIA JAMES E; DROSTE JAMES
权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:EP-0951464-B1
优先权日:1996-11-22
标题:N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
发明人：WU JING; THORSETT EUGENE D; NISSEN JEFFREY S; MABRY THOMAS E; LATIMER LEE H; JOHN VARGHESE; FANG LAWRENCE Y; AUDIA JAMES E
权利人:ELAN PHARM INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.